ClearView Diagnostics

Company profile

About ClearView Diagnostics

Koios Medical is a healthcare technology company specializing in AI-powered clinical decision support software for cancer diagnosis. The company's flagship Smart Ultrasound platform combines artificial intelligence and machine learning to assist radiologists and physicians in accurately diagnosing breast and thyroid cancers through ultrasound imaging. Their Koios DS (Decision Support) software is built on an ensemble of algorithms trained on a proprietary dataset of over 2 million ultrasound images, analyzing 17,900 features per image to classify lesions and render cancer risk assessments aligned with BI-RADS and ATA guidelines. The software has received FDA 510(k) clearance and CE marking, making it a billable procedure. With over 101 installations across 28 countries, Koios Medical serves radiologists, breast imaging specialists, and healthcare systems worldwide. The technology integrates seamlessly into existing PACS workstations, providing real-time analysis in seconds. Clinical studies have demonstrated that the software improves diagnostic accuracy, detects up to 6 more cancers per 100 cases interpreted, and has the potential to reduce benign biopsies by 31-40%. The company's mission focuses on improving cancer survival rates while enhancing workflow efficiency for healthcare providers. Koios Medical has attracted investment from major partners including Mitsui & Co., and continues to expand its global footprint with 1-2 new site activations per week.

Company description · ClearView Diagnostics official website